547 related articles for article (PubMed ID: 34742348)
1. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
[TBL] [Abstract][Full Text] [Related]
2. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
[TBL] [Abstract][Full Text] [Related]
3. Seed amplification assay results illustrate discrepancy in Parkinson's disease clinical diagnostic accuracy and error rates.
Middleton JS; Hovren HL; Kha N; Medina MJ; MacLeod KR; Concha-Marambio L; Jensen KJ
J Neurol; 2023 Dec; 270(12):5813-5818. PubMed ID: 37592136
[TBL] [Abstract][Full Text] [Related]
4. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
[TBL] [Abstract][Full Text] [Related]
5. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
Groveman BR; Orrù CD; Hughson AG; Raymond LD; Zanusso G; Ghetti B; Campbell KJ; Safar J; Galasko D; Caughey B
Acta Neuropathol Commun; 2018 Feb; 6(1):7. PubMed ID: 29422107
[TBL] [Abstract][Full Text] [Related]
6. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid.
Concha-Marambio L; Pritzkow S; Shahnawaz M; Farris CM; Soto C
Nat Protoc; 2023 Apr; 18(4):1179-1196. PubMed ID: 36653527
[TBL] [Abstract][Full Text] [Related]
7. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
Fernandes Gomes B; Farris CM; Ma Y; Concha-Marambio L; Lebovitz R; Nellgård B; Dalla K; Constantinescu J; Constantinescu R; Gobom J; Andreasson U; Zetterberg H; Blennow K
Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
[TBL] [Abstract][Full Text] [Related]
10. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
[TBL] [Abstract][Full Text] [Related]
11. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.
Shahnawaz M; Tokuda T; Waragai M; Mendez N; Ishii R; Trenkwalder C; Mollenhauer B; Soto C
JAMA Neurol; 2017 Feb; 74(2):163-172. PubMed ID: 27918765
[TBL] [Abstract][Full Text] [Related]
12. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
Srivastava A; Alam P; Caughey B
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
[TBL] [Abstract][Full Text] [Related]
13. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
[TBL] [Abstract][Full Text] [Related]
15. High-Yield α-Synuclein Purification and Ionic Strength Modification Pivotal to Seed Amplification Assay Performance and Reproducibility.
Janarthanam C; Clabaugh G; Wang Z; Melvin BR; Scheibe I; Jin H; Anantharam V; Urbauer RJB; Urbauer JL; Ma J; Kanthasamy A; Huang X; Donadio V; Zou W; Kanthasamy AG
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892177
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.
Kang UJ; Boehme AK; Fairfoul G; Shahnawaz M; Ma TC; Hutten SJ; Green A; Soto C
Mov Disord; 2019 Apr; 34(4):536-544. PubMed ID: 30840785
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
[TBL] [Abstract][Full Text] [Related]
19. Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.
Majbour N; Aasly J; Abdi I; Ghanem S; Erskine D; van de Berg W; El-Agnaf O
Neurology; 2022 Nov; 99(21):e2417-e2427. PubMed ID: 36096686
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.
Bellomo G; Paciotti S; Concha-Marambio L; Rizzo D; Wojdaƚa AL; Chiasserini D; Gatticchi L; Cerofolini L; Giuntini S; De Luca CMG; Ma Y; Farris CM; Pieraccini G; Bologna S; Filidei M; Ravera E; Lelli M; Moda F; Fragai M; Parnetti L; Luchinat C
Mol Neurodegener; 2023 Apr; 18(1):20. PubMed ID: 37005644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
